cancer biology Archives
Colon cancer’s cellular crossroads
Mar. 16, 2012—New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
Investigators seek clues to resistance to melanoma drug
Jan. 26, 2012—Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
Protein repairs esophageal DNA damage
Jan. 25, 2012—A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.
Virus-linked cancer gets help from host
Dec. 15, 2011—Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers.
Pathway to colon cancer progression
Dec. 1, 2011—Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis.
Protecting brainpower during radiation
Jun. 29, 2011—Blocking a certain protein during radiation to treat brain cancers could protect the brain’s thinking powers.
Protein related to aging holds breast cancer clues
Feb. 1, 2011—The most common type of breast cancer in older women – estrogen and progesterone receptor (ER/PR) positive breast cancer – has been linked to a protein that fends off aging-related cellular damage. A new study led by Vanderbilt-Ingram Cancer Center researcher David Gius now shows how a deficiency in this aging-associated protein may set the...
